Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Preclinical & Clinical Immunophenotyping Innovation in Acute Myeloid Leukemia Brandon L. Walling, PhD - Associate Director Flow Cytometry at Champions Oncology Determining an effective treatment for AML has been challenging due to the heterogeneity of the disease and the diverse subpopulations that drive the ... 4 weeks ago | 60 mins Improving Preclinical Study Accuracy Using PDX with Next-Gen Multiomic Datasets Stefano Cairo, PhD, Senior Global Scientific Director, Champions Oncology With an estimated 90% of oncology drugs failing clinical trials, there is a critical need for a more robust approach to preclinical and translational ... 2 months ago | 70 mins Selective Ablation of Malignant Cells using Apoptotic Gene Therapy Jailal Ablack, PhD, Head of Preclinical Research, OncoSenX While chemotherapy is a key treatment strategy for many solid tumors, it is rarely selective for tumor cells. OncoSenx has developed an effective suic... 3 years ago | 34 mins Human-derived IO preclinical systems—from in vitro to in vivo and back Amy Wesa, PhD, Head of R&D, Champions Oncology Immuno-oncology (IO) is the study and development of treatments that take advantage of the body’s immune system to fight cancer. IO research has been ... 3 years ago | 39 mins How to Make Preclinical Research a SUCCESS Dr. Anthony Brown - Carrick Therapeutics; Dr. Allan Jordan - Sygnature; Dr. Dima Kuzmin 4BIO; Dr. Alex Moreau - Champions Join the revolution in drug development, based upon forward thinking study design and experimental approaches that are predictive of drug candidates d... 2 years ago | 90 mins Flow Cytometry: Validation and Implementation in a Regulatory Setting Chelsea Riveley, MBA, Head of Business Development, Flow Cytometry Services This webinar provides an overview of flow cytometry and its potential uses in the regulatory setting. Two case studies will be presented to detail the... 3 years ago | 56 mins Rare Oncology Research in the 21st Century Sachin Kulkarni and Juliet M. Moritz Study of rare cancers tends to look more like rare disease research than standard oncology research. This webinar will highlight some of the challenge... 3 years ago | 61 mins Organoids Master Class: Brain Organoids & Their Application in Disease Modeling Richa Singhania, Ph.D., Director, Brain Organoid Core at Weill Cornell Medicine Our guest speaker, Richa Singhania, Ph.D., Director, Brain Organoid Core at Weill Cornell Medicine covers the following: Stem cell models of human br... 3 years ago | 62 mins Organogenesis to Oncogenesis Dr. Joseph Regan Organogenesis to Oncogenesis: Modeling Development and Cancer with Organoids Organoid cell culture allows mammalian stem cells to differentiate and se... 3 years ago | 46 mins Next Generation Humanized Mice for AML and NK Cell Therapy Testing Amy Wesa, PhD, Director of Immuno-Oncology Research at Champions Oncology To develop the most successful novel agents for cancer, researchers require preclinical models that fundamentally epitomize patient populations to ena... 3 years ago | 56 mins Load more
